Chemosensitivity studies in colon cancer cells further revealed LIVIN as a drug resistance gene against etoposide (VP-16) and 5-fluorouracil (5-FU) [86], while attenuation of the protein significantly decreases the size of colon cancer xenograft tumors [86,87]. This evidence concerns the gene BIRC7 and colonic neoplasm.